A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury
Latest Information Update: 03 Mar 2021
At a glance
- Drugs Pelubiprofen (Primary)
- Indications Acute pain; Sprains
- Focus Registrational; Therapeutic Use
- Sponsors Daewon Pharmaceutical
Most Recent Events
- 19 Mar 2019 New trial record
- 17 Mar 2019 Planned primary completion date changed from 29 Dec 2019 to 31 Dec 2019.